Dana-Farber News

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Dana-Farber News
Dec 18, 2024, 18:09 | Blog
Narjust Florez: Our EQUAL study is about to launch
Narjust Florez, Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist…
Sep 14, 2024, 15:42 | Blog
Lauren Merz: A brilliant piece on a nuanced subject that impacts millions of people
Lauren Merz, Hemat/onc fellow at Dana-Farber Institute, shared a post on X: "Cheers to STAT News…
Jun 27, 2024, 20:12 | Blog
Dana-Farber News - Biagio Ricciuti receives IASLC 2024 Young Investigator Grant
Dana-Farber News shared on X: "Congratulations to Biagio Ricciuti, who is a recipient of the IASLC…
Jun 26, 2024, 15:13 | Blog
Toni Choueiri: Our new IMDC paper in ESMO Open led by Kosuke Takemura
Toni Choueiri shared a post by Kosuke Takemura, Staff Urologist at Ganken Hospital, on X: "Our new…
Jun 14, 2024, 15:36 | Blog
Direct Connect Partnership with Massachusetts Firefighters at Dana-Farber
Dana-Farber News made the following post on X: "Dana-Farber announces the launch of the Direct…
May 31, 2024, 15:41 | Societies
Paolo Tarantino: More than 25 ASCO24 oral presentations by Dana-Farber Cancer Institute researchers
Paolo Tarantino shared a post by Dana-Farber Cancer Institute on X: "More than 25 ASCO24…
Apr 20, 2024, 01:23 | Positive
Stuart H. Orkin was named one of TIME's 100 Most Influential People of 2024 - Dana-Farber News
Quoting Dana-Farber News on X/Twitter: "Congratulations to Dana-Farber Cancer Institute's Stuart H. Orkin, MD, who…
Feb 8, 2024, 17:06 | Insight
Narjust Florez: Sexual health in lung cancer made it to the front page of ACS Journal Cancer!
Narjust Florez shared a post by ACS Journal Cancer, on X: A "Grandma! Sexual health…
Jan 28, 2024, 18:44 | Blog
Interim phase 1 results show HPN328 is well tolerated and clinically active for neuroendocrine carcinomas - Dana-Farber News
Dana-Farber News recently shared a post on their X/Twitter page: "ASCO GU24: Interim phase 1…
Dec 22, 2023, 14:31 | Blog
Matthew Davids is the recipient of The Leukemia and Lymphoma Society Clinical Scholar Achievement Award - Dana-Farber News
Dana-Farber News shared a post on their X/Twitter page: "Congratulations to Matthew Davids, who is…
Oct 5, 2023, 15:47 | Insight
New study by Cigall Kadoch, PhD at Dana Farber reveals the sequence-specific contributions of intrinsically disordered proteins known as IDRs, which are implicated in cancer. - Dana-Farber News
Sep 20, 2023, 18:14 | Insight
A potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC)- Dana-Farber News.
Quoting Dana-Farber News on X/Twitter: "Eli Van Allen, Jackson Nyman (Dana-Farber Cancer Institute) and Toni…
All: 12 Posts: 1 - 100
Special Coverage